Louis Navellier’s #1 Stock for 2021

On January 19 at 4 p.m. ET, the man who recommended Google before anyone else will reveal his #1 stock pick for 2021 — for FREE — ticker symbol and all — in a special presentation.

Tue, January 19 at 4:00PM ET
 
 
 
 

5 Stocks With Crummy Sales Growth — RNA ALDR CBMG EXAS GNCA

This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader.

RNA also gets F’s in Earnings Momentum and Equity. For more information, get Portfolio Grader’s complete analysis of RNA stock.

ALDR also gets an F in Earnings Momentum. For more information, get Portfolio Grader’s complete analysis of ALDR stock.

CBMG gets F’s in Earnings Momentum and Equity as well. For more information, get Portfolio Grader’s complete analysis of CBMG stock.

Exact Sciences Corporation (EXAS) is a molecular diagnostics company, focuses on developing a molecular diagnostic technology for the early detection and prevention of colorectal pre-cancer and cancer. EXAS also gets an F in Equity. For more information, get Portfolio Grader’s complete analysis of EXAS stock.

GNCA gets F’s in Analyst Earnings Revisions, Equity and Cash Flow as well. For more information, get Portfolio Grader’s complete analysis of GNCA stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/07/5-stocks-with-crummy-sales-growth-rna-aldr-cbmg-exas-gnca-rna-aldr-cbmg/.

©2021 InvestorPlace Media, LLC